|
Investigational ultra-long-acting insulin degludec reduces hypoglycaemia and improves long-term control
|
28 June 2011 |
|
Novo Nordisk increased operating profit by 27% in 2010
|
02 February 2011 |
|
Novo Nordisk A/S and Emisphere Technologies, Inc. Announce Licence Agreement
|
21 December 2010 |
|
Middle East and North African leaders seek solutions to diabetes threat
|
10 December 2010 |
|
Novo Nordisk presents positive clinical data on two investigational compounds within bleeding disorders
|
07 December 2010 |
|
Diabetes awareness survey reveals alarming figures across the Middle East and Northern Africa regions
|
14 November 2010 |
|
New global survey reveals more than one in three patients fail to take insulin as prescribed
|
21 September 2010 |
|
Patient satisfaction is significantly higher with injectable Victoza®
|
20 September 2010 |
|
Victoza® (liraglutide) provided superior and sustained blood sugar control and weight reduction
|
28 June 2010 |
|
Victoza® to be launched in Japan in June
|
02 June 2010 |